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1. Only neuro-intensivists should care about the brain.     
In acute brain injury, the need for specific expertise on central nervous pathophysiology is 
evident. However, even when the primary reason for ICU admission is extracranial, the brain 
may be affected too, through inadequate substrate and oxygen delivery, blood brain barrier 
leak, harmful effects of sedatives, and excitotoxicity. The resulting spectrum of brain 
dysfunction includes delirium, encephalopathy, coma, and non-convulsive seizures. 
Therefore, all intensive care should integrate neuro-intensive care, with the primary goal to 
preserve the brain [1].  
2. Clinical examination of neuro-critically ill patients is impossible.  
The patient’s clinical state is our most important neuro-monitor. Clinical assessment of 
consciousness, cognition, brainstem, and motor function, should be attempted at least upon 
admission and daily [2]. Sedatives confound neurological examinations, and should be used 
sparingly in severe brain injuries, except for specific indications, such as intracranial pressure 
(ICP) control, seizure treatment, or targeted temperature management (TTM). They should be 
titrated and stopped if no longer indicated.  
3. We should no longer monitor ICP in traumatic brain injury (TBI).  
The ICP monitor has been accused of increasing therapeutic intensity, potentially harming 
patients without improving their outcomes. The Best-TRIP trial [3] is often wrongfully 
interpreted as evidence against ICP monitoring – a view that inappropriately conflates 
monitoring use and therapy titration.  The controversy is not whether to monitor or treat ICP, 
but how this signal should be interpreted and responded to.  
4. The threshold to treat ICP is 20 or 22 mmHg. 
Changing ICP treatment thresholds from 20 to 22 mmHg in influential guidelines [4] imply that 
an ICP of 21 mmHg is fine, whereas an ICP of 23 mmHg should be treated aggressively. The 
absurdity of such strategy is obvious, because it neglects measurement errors, and ignores 
modern concepts such as the ICP intensity-time burden [5]. Interventional studies where 
aggressive treatments, decompressive craniectomy [6] or hypothermia [7], were applied early 
after crossing the 20 mmHg threshold, showed harm rather than benefit. A tiered approach is 
rational, and aggressive measures should probably be reserved for sustained ICP elevations 
above 25-30 mmHg unresponsive to lower-tier therapy.  
5. Ketamine increases the ICP.   
Ketamine-induced ICP elevations were reported in small studies in non-ventilated (and not 
acutely brain-injured) patients [8]. In fact, ketamine, as an adjunct in sedated mechanically 
ventilated patients, might decrease the ICP [9, 10], produce neuroprotection through  NMDA-
receptor antagonism [11], suppress harmful cortical spreading depolarisations [12], and 
control refractory seizures [13].  
6. Subarachnoid hemorrhage (SAH) patients should get Triple H therapy.  
Aggressive fluid loading (with consequent haemodilution), coupled with vasopressor 
administration to increase arterial blood pressure (ABP), was used in the past in the hope of 
preventing delayed cerebral ischemia (DCI) and vasospasm. This strategy is discredited, and 
might be deleterious in this population, where the median age is 50-60 years, and 
cardiopulmonary complications are common. Current recommendations [14] advise against 
haemodilution, and to aim for normovolemia. Clinical DCI should prompt a stepwise trial of 
ABP augmentation, titrated to neurological assessment. Where diagnosis or response to 
therapy are uncertain, additional investigations can help confirm or refute the diagnosis of 
DCI - not all late neurological deterioration in SAH is due to vasospasm.  
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7. There is no need to control the temperature after cardiac arrest (CA). 
The evidence for TTM at 32-34°C after out-of-hospital CA, is less robust than initially assumed 
[15]. No difference in outcome was found between TTM at 33°C or at 36°C [16]. However, 
these results do not justify neglecting temperature control after CA. Targeting 32-34°C may 
still be defensible because of equipoise between targets, but many sites involved in the TTM 
trial have adopted the 36°C target [17], since it avoids potential adverse events of more 
aggressive cooling.  
8. Hypoglycemia is harmful for the brain, hyperglycemia is not.  
The optimal glycemic target for the injured brain is controversial. Tight blood glucose control 
to the normal fasting range (TGC) increases the risk of (deep) hypoglycemia, especially in 
inexperienced hands. In small observational studies, the (lower) normoglycemic range has 
been associated with low cerebral microdialysis glucose values [18], raising concerns about 
substrate delivery. On the other hand, hyperglycemia is an independent predictor of poor 
neurological outcome and death after CA [19].  According to a recent meta-analysis, the use 
of TGC showed a small but significant reduction in the risk of poor neurological outcomes in 
TBI [20]. So, even when the discussion on the optimal glycemic target is far from resolved, it 
is important not to ignore that both hypo-and hyperglycemia are associated with worse 
clinical outcomes in neuro-critically ill patients.  
9. In acute ischemic stroke (AIS), revascularization should be done within 3 hours of 
symptom onset.  
The conventional time window for thrombolysis in AIS is 3 hours, extendable to 4.5 hours in 
patients ≤80 y of age, without a history of both diabetes mellitus and prior stroke combined, 
a National Institutes of Health Stroke Scale (NIHSS) score of ≤25, not taking any oral 
anticoagulants, and without imaging evidence of ischemic injury involving more than 1/3 of 
middle cerebral artery territory [21]. When mechanical thrombectomy is considered, the 
recommended timeframe is 6 hours post-ictus, but specific penumbra-like conditions on 
perfusion imaging allow for longer time-windows up to 16 hours [22]. General anesthesia 
during thrombectomy should be avoided [23].  
10. Blood pressure control in intracerebral hemorrhage (ICH): contradictory trials.  
Interpreting recent trials [24–26] on the treatment of hypertension after ICH is complicated 
by differences in inclusion criteria, intervention timing, outcomes, antihypertensive drugs, and 
systolic blood pressure (SBP) targets. All these studies were conducted in patients with 
relatively small ICH volumes, with varying latency to achieving target SBP (ranging from 4.5 to 
24h). Early intensive SBP control to targets above 140 mmHg reduces hematoma expansion, 
but does not improve neurological outcome or mortality.  More aggressive SBP reduction to 
110-140 mmHg in the ATACH-2 study [26] found no incremental benefit as compared to the 
140-180 mmHg range, but a higher rate of renal complications. In brief, SBP control in ICH may 
reduce hematoma expansion, but not below 140 mmHg. 
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Table 1: 10 false beliefs in neurocritical care.  
 
 
False belief 
 
New concept 
Only neuro-intensivists should care about 
the brain.     
All intensive care integrates neuro-
intensive care.  
Clinical examination of neuro-critically ill 
patients is impossible. 
Clinical assessment of neuro-critically ill 
patients is more reliable than any 
neuromonitor.  
We should no longer monitor the 
intracranial pressure in traumatic brain 
injury. 
Don’t confuse the monitor for the 
treatment.  
The threshold to treat the intracranial 
pressure is 20 or 22 mmHg. 
There is no universal ICP threshold for all 
patients. ICP should be interpreted 
together with clinical signs, imaging, and 
other multimodality monitors. Aggressive 
and potentially harmful therapeutic 
measures should be reserved for 
sustained ICP elevations above 25-30 
mmHg unresponsive to lower-tier therapy.  
Ketamine increases the ICP In mechanically ventilated patients 
receiving other sedatives, ketamine can 
reduce ICP, provide neuroprotection, 
control seizures and reduce cortical 
spreading depression.  
Subarachnoid hemorrhage patients should 
get ‘Triple H’ therapy. 
Haemodilution is not recommended, and 
euvolemia should be targeted initially. A 
clinical picture of delayed cerebral 
ischemia (DCI) should promote blood 
pressure augmentation titrated to 
neurology. Remember that not all 
neurological deterioration in SAH is DCI.  
There is no need to control the 
temperature after cardiac arrest. 
Pre-hospital cooling is not beneficial.  
Strict normothermia (~36°C) or 
hypothermia (~33°C) are equally 
beneficial; the former has fewer side 
effects.  
Hypoglycemia is harmful for the brain, 
hyperglycemia is not. 
Both hypo-and hyperglycemia are 
associated with worse clinical outcomes.  
In acute ischemic stroke, revascularization 
should be done within 3 hours of symptom 
onset. 
In selected patients, the window for IV 
thrombolytic therapy can be extended to 
4,5 hours. Thrombectomy can be 
beneficial up to 16 h in some patients 
(selected with advanced imaging).  
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Blood pressure control in intracerebral 
hemorrhage (ICH):  contradictory trials.  
 
In ICH, early blood pressure control is 
feasible, and reduces the rate of 
hematoma expansion, but does not 
improve outcome. There is no additional 
benefit for blood pressure reduction in the 
110-139 mmHg range, compared with 
goals of 140-179.  
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1. Only neuro-intensivists should care about the brain.     
In acute brain injury, the need for specific expertise on central nervous pathophysiology is 
evident. However, even when the primary reason for ICU admission is extracranial, the brain 
may be affected too, through inadequate substrate and oxygen delivery, blood brain barrier 
leak, harmful effects of sedatives, and excitotoxicity. The resulting spectrum of brain 
dysfunction includes delirium, encephalopathy, coma, and non-convulsive seizures. 
Therefore, all intensive care should integrate neuro-intensive care, with the primary goal to 
preserve the brain [1].  
2. Clinical examination of neuro-critically ill patients is impossible.  
The patient’s clinical state is our most important neuro-monitor. Clinical assessment of 
consciousness, cognition, brainstem, and motor function, should be attempted at least upon 
admission and daily [2]. Sedatives confound neurological examinations, and should be used 
sparingly in severe brain injuries, except for specific indications, such as intracranial pressure 
(ICP) control, seizure treatment, or targeted temperature management (TTM). They should be 
titrated and stopped if no longer indicated.  
3. We should no longer monitor ICP in traumatic brain injury (TBI).  
The ICP monitor has been accused of increasing therapeutic intensity, potentially harming 
patients without improving their outcomes. The Best-TRIP trial [3] is often wrongfully 
interpreted as evidence against ICP monitoring – a view that inappropriately conflates 
monitoring use and therapy titration.  The controversy is not whether to monitor or treat ICP, 
but how this signal should be interpreted and responded to.  
4. The threshold to treat ICP is 20 or 22 mmHg. 
Changing ICP treatment thresholds from 20 to 22 mmHg in influential guidelines [4] imply that 
an ICP of 21 mmHg is fine, whereas an ICP of 23 mmHg should be treated aggressively. The 
absurdity of such strategy is obvious, because it neglects measurement errors, and ignores 
modern concepts such as the ICP intensity-time burden [5]. Interventional studies where 
aggressive treatments, decompressive craniectomy [6] or hypothermia [7], were applied early 
after crossing the 20 mmHg threshold, showed harm rather than benefit. A tiered approach is 
rational, and aggressive measures should probably be reserved for sustained ICP elevations 
above 25-30 mmHg unresponsive to lower-tier therapy.  
5. Ketamine increases the ICP.   
Ketamine-induced ICP elevations were reported in small studies in non-ventilated (and not 
acutely brain-injured) patients [8]. In fact, ketamine, as an adjunct in sedated mechanically 
ventilated patients, might decrease the ICP [9, 10], produce neuroprotection through  NMDA-
receptor antagonism [11], suppress harmful cortical spreading depolarisations [12], and 
control refractory seizures [13].  
6. Subarachnoid hemorrhage (SAH) patients should get Triple H therapy.  
Aggressive fluid loading (with consequent haemodilution), coupled with vasopressor 
administration to increase arterial blood pressure (ABP), was used in the past in the hope of 
preventing delayed cerebral ischemia (DCI) and vasospasm. This strategy is discredited, and 
might be deleterious in this population, where the median age is 50-60 years, and 
cardiopulmonary complications are common. Current recommendations [14] advise against 
haemodilution, and to aim for normovolemia. Clinical DCI should prompt a stepwise trial of 
ABP augmentation, titrated to neurological assessment. Where diagnosis or response to 
therapy are uncertain, additional investigations can help confirm or refute the diagnosis of 
DCI - not all late neurological deterioration in SAH is due to vasospasm.  
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7. There is no need to control the temperature after cardiac arrest (CA). 
The evidence for TTM at 32-34°C after out-of-hospital CA, is less robust than initially assumed 
[15]. No difference in outcome was found between TTM at 33°C or at 36°C [16]. However, 
these results do not justify neglecting temperature control after CA. Targeting 32-34°C may 
still be defensible because of equipoise between targets, but many sites involved in the TTM 
trial have adopted the 36°C target [17], since it avoids potential adverse events of more 
aggressive cooling.  
8. Hypoglycemia is harmful for the brain, hyperglycemia is not.  
The optimal glycemic target for the injured brain is controversial. Tight blood glucose control 
to the normal fasting range (TGC) increases the risk of (deep) hypoglycemia, especially in 
inexperienced hands. In small observational studies, the (lower) normoglycemic range has 
been associated with low cerebral microdialysis glucose values [18], raising concerns about 
substrate delivery. On the other hand, hyperglycemia is an independent predictor of poor 
neurological outcome and death after CA [19].  According to a recent meta-analysis, the use 
of TGC showed a small but significant reduction in the risk of poor neurological outcomes in 
TBI [20]. So, even when the discussion on the optimal glycemic target is far from resolved, it 
is important not to ignore that both hypo-and hyperglycemia are associated with worse 
clinical outcomes in neuro-critically ill patients.  
9. In acute ischemic stroke (AIS), revascularization should be done within 3 hours of 
symptom onset.  
The conventional time window for thrombolysis in AIS is 3 hours, extendable to 4.5 hours in 
patients ≤80 y of age, without a history of both diabetes mellitus and prior stroke combined, 
a National Institutes of Health Stroke Scale (NIHSS) score of ≤25, not taking any oral 
anticoagulants, and without imaging evidence of ischemic injury involving more than 1/3 of 
middle cerebral artery territory [21]. When mechanical thrombectomy is considered, the 
recommended timeframe is 6 hours post-ictus, but specific penumbra-like conditions on 
perfusion imaging allow for longer time-windows up to 16 hours [22]. General anesthesia 
during thrombectomy should be avoided [23].  
10. Blood pressure control in intracerebral hemorrhage (ICH): contradictory trials.  
Interpreting recent trials [24–26] on the treatment of hypertension after ICH is complicated 
by differences in inclusion criteria, intervention timing, outcomes, antihypertensive drugs, and 
systolic blood pressure (SBP) targets. All these studies were conducted in patients with 
relatively small ICH volumes, with varying latency to achieving target SBP (ranging from 4.5 to 
24h). Early intensive SBP control to targets above 140 mmHg reduces hematoma expansion, 
but does not improve neurological outcome or mortality.  More aggressive SBP reduction to 
110-140 mmHg in the ATACH-2 study [26] found no incremental benefit as compared to the 
140-180 mmHg range, but a higher rate of renal complications. In brief, SBP control in ICH may 
reduce hematoma expansion, but not below 140 mmHg. 
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Table 1: 10 false beliefs in neurocritical care.  
 
 
False belief 
 
New concept 
Only neuro-intensivists should care about 
the brain.     
All intensive care integrates neuro-
intensive care.  
Clinical examination of neuro-critically ill 
patients is impossible. 
Clinical assessment of neuro-critically ill 
patients is more reliable than any 
neuromonitor.  
We should no longer monitor the 
intracranial pressure in traumatic brain 
injury. 
Don’t confuse the monitor for the 
treatment.  
The threshold to treat the intracranial 
pressure is 20 or 22 mmHg. 
There is no universal ICP threshold for all 
patients. ICP should be interpreted 
together with clinical signs, imaging, and 
other multimodality monitors. Aggressive 
and potentially harmful therapeutic 
measures should be reserved for 
sustained ICP elevations above 25-30 
mmHg unresponsive to lower-tier therapy.  
Ketamine increases the ICP In mechanically ventilated patients 
receiving other sedatives, ketamine can 
reduce ICP, provide neuroprotection, 
control seizures and reduce cortical 
spreading depression.  
Subarachnoid hemorrhage patients should 
get ‘Triple H’ therapy. 
Haemodilution is not recommended, and 
euvolemia should be targeted initially. A 
clinical picture of delayed cerebral 
ischemia (DCI) should promote blood 
pressure augmentation titrated to 
neurology. Remember that not all 
neurological deterioration in SAH is DCI.  
There is no need to control the 
temperature after cardiac arrest. 
Pre-hospital cooling is not beneficial.  
Strict normothermia (~36°C) or 
hypothermia (~33°C) are equally 
beneficial; the former has fewer side 
effects.  
Hypoglycemia is harmful for the brain, 
hyperglycemia is not. 
Both hypo-and hyperglycemia are 
associated with worse clinical outcomes.  
In acute ischemic stroke, revascularization 
should be done within 3 hours of symptom 
onset. 
In selected patients, the window for IV 
thrombolytic therapy can be extended to 
4,5 hours. Thrombectomy can be 
beneficial up to 16 h in some patients 
(selected with advanced imaging).  
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Blood pressure control in intracerebral 
hemorrhage (ICH):  contradictory trials.  
 
In ICH, early blood pressure control is 
feasible, and reduces the rate of 
hematoma expansion, but does not 
improve outcome. There is no additional 
benefit for blood pressure reduction in the 
110-139 mmHg range, compared with 
goals of 140-179.  
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